Opioid-associated environmental stimuli elicit robust immune-alte ring effects via stimulation of a neural circuitry that includes the basolateral amygdala and nucleus accumbens. These brain regions are known to have both direct and indirect connections with the hippocampus. Thus, the present study evaluated whether the dorsal hippocampus (DH), and more specifically interleukin-1 beta (IL-1b) within the DH, is necessary for the expression of heroin-induced condit ioned immunomodulation. Rats received five Pavlovian pairings of systemic heroin administration (1.0 mg/kg , SC) with placement into a distinct environment (conditioned stimulus, CS). Six days after conditioning, a GABA A/B agonist cocktail or IL-1 b small interfering RNA (siRNA) was microinfused into the DH to inhibit neuronal activity or IL-1 b gene expression prior to CS or home cage exposure. Control animals received saline or negative control siRNA microinfusions. Furthermore, all rats received systemic administration of lipopolysaccharide (LPS) to stimulate proinflammatory nitric oxide production. CS exposure suppress ed LPS-indu ced nitric oxide production relative to home cage exposure . Inactivation of, or IL-1 b silencing in, the DH disrupted the CS-induced suppression of nitric oxide production relative to vehicle or negative control siRNA treatment. These results are the first to show a role for DH IL-1 b expression in heroin-conditioned suppression of a proinflammatory immune response.
Introduction
Opioids exert a number of detrimental physiolog ical effects, including disruption of immune system functioning , that diminish host defense mechanisms and increase susceptibi lity to infectious disease states (Simonovska et al., 2011 ) . For instance, acute heroin administrat ion results in the suppression of the peripheral proinflammatory mediator inducible nitric oxide synthase (iNOS), the enzyme that is responsible for nitric oxide production (Lysle and How, 2000 ) . Nitric oxide production by immune cells, particular ly macrophages , alters the course of microbial resistance and autoimmune diseases (Breitbach et al., 2006; Choi et al., 2006; Green et al., 1990 Green et al., , 1993 MacMicking et al., 1995; Murray and Nathan, 1999; Oates and Gilkeson, 2006; Rossi et al., 1999; Stofkova et al., 2006; Vincendeau et al., 1992; Wei et al., 1995 ) , provides resistance to viral infections and exerts significant tumor cytotoxicity (Green et al., 1993; Hibbs et al., 1987; Hrabak et al., 2006; Karupiah et al., 1993 ) . Moreover, mice lacking the gene for iNOS exhibit increased susceptibi lity to parasitic and bacterial infections (Lindgren et al., 2004; Wei et al., 1995 ) , suggestin g that iNOS acts as an antimicrobi al agent. In addition, nitric oxide has numerous immunoreg ulatory functions, including the modulation of cytokine production (Marcinkiewicz and Chain, 1993; Taylor-Robi nson et al., 1994; Van Dervort et al., 1994 ) and the suppression of lymphocyte proliferation (Albina and Henry, 1991 ). Thus, iNOS plays a critical role in immune function and heroin-induced suppression of nitric oxide likely increases susceptibi lity to infection following heroin administ ration.
Opioid-in duced suppression of nitric oxide and other immune paramete rs are mediated by central nervous system (CNS) mechanisms. Consistent with this, central administration of the opioid antagoni st, N-methylnaltr exone (a form of naltrexon e which does not readily penetrate the blood-brain barrier), attenuates the immunomo dulatory effects of systemic morphine treatment, whereas peripheral administration of N-methylnaltr exone is ineffective (Fecho et al., 1996; Lysle et al., 1996 ) . Furthermore, microinjection of morphine directly into the periaqueductal gray, a brain region rich in opioid receptors, suppresses natural killer (NK) cell cytotoxic ity, an effect that can be blocked by peripheral administration of the opioid antagoni st naltrexon e (Weber and Pert, 1989) . Interestingly, following repeated pairing with opioids, environmental stimuli can acquire the ability to induce alterations in immune function similar to those produced by the drug itself (Coussons -Read et al., 1994a,b; Coussons et al., 1992; Luecken and Lysle, 1992; Lysle et al., 1988; Lysle and Ijames, 2002; Szczytkowsk i et al., 2011; Szczytkowski and Lysle, 2007 , 2008 , 2010 . These effects are the result of Pavlovian conditioning, and
